DMPK and glioblastoma: Moreover, proteoliposomes with sapC-PUMA and sapC-PUMA-DM show increased cytotoxicity in glioblastoma cells relative to sapC-only proteoliposomes, which proves that the presence of PUMABH3 has an additive effect in reducing cell viability.